Navigation Links
Pacira Pharmaceuticals, Inc. Expands Development Collaborations for DepoFoam(R)
Date:4/15/2008

SAN DIEGO, April 15 /PRNewswire/ -- Pacira Pharmaceuticals, Inc. today announced a collaboration with Amylin Pharmaceuticals, Inc. for the development of sustained release injectable products based on the DepoFoam(R) technology platform from Pacira. The companies will work together to enhance the dosing profile for compounds within Amylin's early research and development pipeline. The goal of the collaboration is to develop multiple products based on sustained release, subcutaneous injection.

Dave Stack, President and CEO of Pacira stated, "In addition to our own lead development candidate, DepoBupivacaine(TM), we believe that delivery of Amylin's compounds using the DepoFoam(R) technology would create significant value for patient care, our partners, and Pacira."

"Pacira's DepoFoam(R) technology is an attractive delivery system and Amylin is excited to apply this technology to our peptide and protein therapeutics platform," said Christopher Rhodes, Ph.D., Executive Director, Pharmaceutical Sciences of Amylin. "This collaboration fits well with Amylin's research and development activities, which leverage our expertise in metabolism to develop potential therapies for diabetes and obesity."

Terms of the agreement are not disclosed at this time.

About Pacira

Pacira is an acute care specialty pharmaceutical company with a primary focus on developing Products which satisfy the needs of our customers in the institutional marketplace. The Company utilizes DepoFoam(R) delivery technology to cost-effectively improve patient care through enhanced dosing and administration profiles. Currently, the Company is developing DepoBupivacaine(TM) in phase III clinical studies for postsurgical pain. Revenues are generated from two approved products which are marketed by partners: DepoCyt(R) for lymphomatous meningitis and DepoDur(R) for post- surgical pain. Additional information about Pacira is available at '/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Laureate Pharma Announces Manufacturing Agreement With Alopexx Pharmaceuticals, LLC
2. Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights
3. Aida Pharmaceuticals, Inc. Acquires High-Level Research Institute in the Peoples Republic of China
4. Jazz Pharmaceuticals, Inc. Announces Expansion of Senior Debt
5. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
6. Jazz Pharmaceuticals, Inc. Announces Webcast of March 13 Investor Meeting
7. Acura Pharmaceuticals, Inc. Reports 2007 4th Quarter and Annual Financial Results; Sets 2008 Expectations
8. Investor Alert from Cauley Bowman Carney & Williams, PLLC: Update on Proposed Acquisition of CollaGenex Pharmaceuticals, Inc. - CGPI
9. Strativa Pharmaceuticals, a Division of Par Pharmaceutical, Announces the Discontinuation of the Development Program for Pafuramidine
10. Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2007 Financial Results
11. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Fourth Quarter and Year-End 2007 Financial Results on Monday, February 25, at 8:30 A.M. EST
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... August 28, 2014 Whitehouse Laboratories is ... term partnership with PTI Inspection Systems that ... state of the art leak testing method development and ... instruments currently available. As part of this agreement, Whitehouse ... Voltage Leak Detection Instrument developed and manufactured by ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Green & ... in Series B funding and secured Otter Capital as ... capital will accelerate commercialization of GGI’s Agriplier™ technology, building ... types. , “Since our first meeting, we have ... the biological product space,” said Alan Sobba, President and ...
(Date:8/27/2014)... August 27, 2014 In 2013, ... Lawrence Livermore National Security LLC (LLNS), ... and deliver a state-of-the-art laser system for the ... Beamlines), under construction in the Czech Republic. , ... laser system, called the " High repetition-rate Advanced ...
(Date:8/27/2014)... 27, 2014   MSC , a healthcare performance ... announced the appointment of Mary Beth Loesch ... years of experience preparing companies for rapid growth and ... Vice President of Corporate Development and Healthcare. In that ... , as well as corporate strategy and marketing. Previously, ...
Breaking Biology Technology:Whitehouse Labs Renews Partnership with PTI Inspection Systems 2Whitehouse Labs Renews Partnership with PTI Inspection Systems 3Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 2Green & Grow Inc. Secures $6M Series B Funding from Otter Capital 3LLNL Synchs up with ELI Beamlines on Timing System 2LLNL Synchs up with ELI Beamlines on Timing System 3MSC names Mary Beth Loesch President and CEO 2
... Inc. (OTCBB: MDXG), an integrated developer, manufacturer and ... processed from human amniotic membrane, announced today that ... convertible notes and warrants has been fully subscribed. ... October 15, 2011, the Company received $5,000,000 in ...
... many Americans are resolving to address financial issues or lose ... are looking to find answers to an important question – ... which was commissioned by Identigene, the largest direct-to-consumer DNA paternity ... the only paternity test available at the drug store, reveals ...
... Cord Blood America, Inc . ( http://www.cordblood-america.com ) ... blood stem cell preservation company focused on bringing ... and internationally, is pleased to announce it has signed an ... laboratory for the National Children,s Leukemia Foundation (NCLF), New York. ...
Cached Biology Technology:MiMedx Group Completes $5,000,000 Private Placement 2MiMedx Group Completes $5,000,000 Private Placement 3Survey Reveals Paternity Questions Loom for More Than One in 10 Americans 2Survey Reveals Paternity Questions Loom for More Than One in 10 Americans 3Cord Blood America Announces Exclusive Agreement With National Children's Leukemia Foundation to Store Stem Cells 2
(Date:8/29/2014)... A leading U.S. Ebola researcher from the University of Texas ... a blend of three monoclonal antibodies can completely protect monkeys ... days after infection, at a time when the disease is ... written an editorial for Nature discussing advances in ... Marburg virus are among the most deadly of pathogens, with ...
(Date:8/29/2014)... researchers explored the type and number of connections in ... plays on robustness in a study published in ... found that the assortativity signature contributes to a network,s ... that varying the out-out assortativity of TFN models has ... the other three types of assortativity," said Dov A. ...
(Date:8/29/2014)... news release is available in German . ... chemical signals between organisms is considered the oldest form ... interactions between conspecifics, for example, the sexual attraction between ... social responses and to coordinate reproductive behavior in males ... the University of the Algarve in Faro, Portugal, and ...
Breaking Biology News(10 mins):Leading Ebola researcher at UTMB says there's an effective treatment for Ebola 2Assortativity signatures of transcription factor networks contribute to robustness 2Ready for mating at the right time 2Ready for mating at the right time 3
... JUPITER, FL -- Scripps Florida scientists have been awarded ... part of the National Institutes of Health, to study ... be effective in controlling pain without the unwanted side ... and Vicoden. Laura Bohn, an associate professor ...
... Adding prebiotic ingredients to infant formula helps colonize ... bacteria, and probiotics enhance immunity in formula-fed infants, two ... bacteria that live in a baby,s intestine are all-important ... off infections," said Kelly Tappenden, a U of I ...
... quickly identifying them can be crucial to stopping an ... hours and days. But not for much longer. ... electrical engineering at the University of Tennessee, Knoxville, and ... at the UT Institute of Agriculture Center for Wildlife ...
Cached Biology News:Scripps Florida scientists awarded $3 million to develop new, more effective pain treatments 2New infant formula ingredients boost babies' immunity by feeding their gut bacteria 2University of Tennessee researchers invent device to rapidly detect infectious disease 2
... PBL's bioassays for interferons are cytopathic effect inhibition ... Sample types include; tissue culture supernatents; serum ... these assays, one unit is defined as the ... the cytopathic effect of viral infection by 50%. ...
Request Info...
... are available in two product models - the ... models is that the 6000AT+ includes a membrane ... aerosol for improved detection limits and reduced oxides. ... range of elements by 10-40 times. Note that ...
... available in two product models - the 5000AT+ ... is that the 6000AT+ includes a membrane desolvation ... for improved detection limits and reduced oxides. The ... of elements by 10-40 times. Note that with ...
Biology Products: